| Reference |
|---|
Adachi Y, Terakura S, Osaki M, Okuno Y, Sato Y, Sagou K, et al. Cullin-5 deficiency promotes chimeric antigen receptor T cell effector functions potentially via the modulation of JAK/STAT signaling pathway. Nat Commun. 2024;15:10376 pubmed publisher |
Gong G, Bilanges B, Allsop B, Masson G, Roberton V, Askwith T, et al. A small-molecule PI3Kα activator for cardioprotection and neuroregeneration. Nature. 2023;618:159-168 pubmed publisher |
Marona P, G xf3 rka J, Kwapisz O, Jura J, Rys J, Hoffman R, et al. Resistance to tyrosine kinase inhibitors promotes renal cancer progression through MCPIP1 tumor-suppressor downregulation and c-Met activation. Cell Death Dis. 2022;13:814 pubmed publisher |
Nakadate Y, Kawakami A, Sato H, Sato T, Oguchi T, Omiya K, et al. PI3K/Akt pathway mediates the positive inotropic effects of insulin in Langendorff-perfused rat hearts. Sci Rep. 2022;12:9793 pubmed publisher |
Zhang S, Bai P, Lei D, Liang Y, Zhen S, Bakiasi G, et al. Degradation and inhibition of epigenetic regulatory protein BRD4 exacerbate Alzheimer's disease-related neuropathology in cell models. J Biol Chem. 2022;298:101794 pubmed publisher |
Carpintero Fernández P, Borghesan M, Eleftheriadou O, Pan Castillo B, Fafián Labora J, Mitchell T, et al. Genome wide CRISPR/Cas9 screen identifies the coagulation factor IX (F9) as a regulator of senescence. Cell Death Dis. 2022;13:163 pubmed publisher |
Pignochino Y, Crisafulli G, Giordano G, Merlini A, Berrino E, Centomo M, et al. PARP1 Inhibitor and Trabectedin Combination Does Not Increase Tumor Mutational Burden in Advanced Sarcomas-A Preclinical and Translational Study. Cancers (Basel). 2021;13: pubmed publisher |
Giordano G, Merlini A, Ferrero G, Mesiano G, Fiorino E, Brusco S, et al. EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and Chondrosarcoma. Cells. 2021;10: pubmed publisher |
Zalcman N, Gutreiman M, Shahar T, Weller M, Lavon I. Androgen Receptor Activation in Glioblastoma Can Be Achieved by Ligand-Independent Signaling through EGFR-A Potential Therapeutic Target. Int J Mol Sci. 2021;22: pubmed publisher |
Lai Y, Chao C, Liao C, Lee T, Hsu J, Chou W, et al. Epithelial-mesenchymal transition induced by SARS-CoV-2 required transcriptional upregulation of Snail. Am J Cancer Res. 2021;11:2278-2290 pubmed |
Rodrigues Moita A, Bandolik J, Hansen F, Kurz T, Hamacher A, Kassack M. Priming with HDAC Inhibitors Sensitizes Ovarian Cancer Cells to Treatment with Cisplatin and HSP90 Inhibitors. Int J Mol Sci. 2020;21: pubmed publisher |
Borghesan M, Fafián Labora J, Eleftheriadou O, Carpintero Fernández P, Pàez Ribes M, Vizcay Barrena G, et al. Small Extracellular Vesicles Are Key Regulators of Non-cell Autonomous Intercellular Communication in Senescence via the Interferon Protein IFITM3. Cell Rep. 2019;27:3956-3971.e6 pubmed publisher |
Gökyildirim M, Grandel U, Hattar K, Dahlem G, Schuetz E, Leinberger F, et al. Targeting CREB-binding protein overrides LPS induced radioresistance in non-small cell lung cancer cell lines. Oncotarget. 2018;9:28976-28988 pubmed publisher |
Egan S, Karasik E, Ellis L, Gollnick S. miR-30e* is overexpressed in prostate cancer and promotes NF-?B-mediated proliferation and tumor growth. Oncotarget. 2017;8:67626-67638 pubmed publisher |
Kim H, Hwang H, Lee H, Hong H. L1 Cell Adhesion Molecule Promotes Migration and Invasion via JNK Activation in Extrahepatic Cholangiocarcinoma Cells with Activating KRAS Mutation. Mol Cells. 2017;40:363-370 pubmed publisher |
Nakadate Y, Sato H, Oguchi T, Sato T, Kawakami A, Ishiyama T, et al. Glycemia and the cardioprotective effects of insulin pre-conditioning in the isolated rat heart. Cardiovasc Diabetol. 2017;16:43 pubmed publisher |
